Hikma Pharmaceuticals recalls Lorazepam injection vials due to impurities detected in samples. Affected lots expire by June 2023. Consumers should contact Hikma for details.
Failed Impurities/Degradation Specifications: Out-of-specification results observed for total related compounds during testing of retain samples.
Hikma Pharmaceuticals is recalling Lorazepam injection vials that tested with impurities. This could pose a health risk if used improperly. The recall affects specific lots with expiration dates up to June 2023.
The testing found impurities in the injection samples that may not be safe for medical use. This could lead to adverse health effects if the medication is administered.
Prescription patients who received the recalled Lorazepam injection vials. Those with specific lot numbers and expiration dates listed in the recall are most at risk.
Check the vial label for the lot number and expiration date. The affected vials have specific lot numbers and expire by June 2023.
Look for the lot number and expiration date on the vial label to determine if it is affected.
The recall indicates impurities were found in samples, but the official notice does not specify if the product is safe to use.
The recall record does not specify a remedy or action for affected products.
Check the vial label for the lot number and expiration date listed in the recall.
We’ve drafted a message you can send Hikma Pharmaceuticals to request your refund or repair — edit it as you like.
Subject: Recall D-1307-2022 — Hikma Pharmaceuticals Hikma Pharmaceuticals Hello, I own a Hikma Pharmaceuticals that is covered by recall D-1307-2022 from Hikma Pharmaceuticals. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
